Literature DB >> 1980614

Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables.

C Masserini1, A Vita, R Basile, R Morselli, P Boato, C Peruzzi, L Pugnetti, P Ferrante, C L Cazzullo.   

Abstract

Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980614     DOI: 10.1016/0920-9964(90)90008-u

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

Authors:  I Wilke; V Arolt; M Rothermundt; C Weitzsch; M Hornberg; H Kirchner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 2.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

Review 3.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

5.  Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins.

Authors:  M H Rapaport; E F Torrey; C G McAllister; D L Nelson; D Pickar; S M Paul
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.

Authors:  Brian J Miller; Andrew Mellor; Peter Buckley
Journal:  Brain Behav Immun       Date:  2012-09-11       Impact factor: 7.217

7.  Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status.

Authors:  Roberto Delle Chiaie; Brunella Caronti; Francesco Macrì; Sandra Campi; Marzia Marino; Alessandra Corrado; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-08-23

8.  A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.

Authors:  Toby Pillinger; Emanuele F Osimo; Stefan Brugger; Valeria Mondelli; Robert A McCutcheon; Oliver D Howes
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.